Cyto Biotech: Announcement of Resolutions of the Second Extraordinary Shareholders Meeting in 2025
Securities code: 300583 Securities abbreviation: Cyto Biotechnology Announcement number: 2025-046
Shandong Saito Biotechnology Co., Ltd.
Announcement of Resolutions of the Second Extraordinary Shareholders Meeting in 2025
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Special tips:
There is no veto of the resolution at this shareholders’ meeting;
This shareholders’ meeting does not involve changes to the resolutions of the previous shareholders’ meeting.
1. Meeting convening and attendance
(1) Meeting status
The notice of the second extraordinary shareholders' meeting of Shandong Saito Biotechnology Co., Ltd. (hereinafter referred to as the "Company") in 2025 was issued in the form of an announcement on December 6, 2025. This shareholders' meeting was held by a combination of on-site voting and online voting. Among them, its on-site meeting will be held in the company's conference room at 14:30 on December 26, 2025 (Friday); the online voting time through the Shenzhen Stock Exchange trading system is: December 26, 2025 9:15-9:25, 9:30-11:30, 13:00-15:00. The specific time for voting through the Shenzhen Stock Exchange Internet system is 9:15-15:00 on December 26, 2025.
This meeting was convened by the company's board of directors and chaired by Mr. Mickey. All the company's directors, senior managers and witnessing lawyers attended or attended the meeting. The convening, holding and voting procedures of this shareholders' meeting comply with the provisions of the Company Law, the Rules of Shareholders' Meetings of Listed Companies and other relevant laws, administrative regulations, departmental rules, normative documents and the Articles of Association, and are legal and valid.
(2) Meeting attendance
A total of 84 shareholders and shareholders' authorized representatives attended this shareholders' meeting, representing 74,546,402 shares, accounting for 39.2966% of the company's total voting shares.
Among them, 5 shareholders and shareholder representatives attended the on-site shareholders' meeting, representing 73,551,882 shares with voting rights, accounting for 38.7723% of the company's total voting shares; 79 shareholders participated in online voting, representing 994,520 shares, accounting for 0.5243% of the company's total voting shares.
2. Proposal review and voting status
This shareholders' meeting adopted a voting method that combines on-site registered voting and online voting, and reviewed and approved the following proposals:
- Consider and approve the "Proposal on Changing Investment Projects with Partial Raised Funds"
Voting results: 74,214,202 shares were approved, accounting for 99.5544% of the total number of shares with valid voting rights present at this shareholders' meeting; 274,200 shares were opposed, accounting for 0.3678% of the total number of shares with valid voting rights present at this shareholders' meeting; 58,000 shares were abstained (of which 0 shares abstained by default due to non-voting), accounting for 0.0778% of the total number of shares with valid voting rights present at this shareholders' meeting.
Total voting results of small and medium shareholders:
662,420 shares were approved, accounting for 66.6003% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 274,200 shares were opposed, accounting for 27.5683% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 58,000 abstained shares (of which 0 shares abstained by default due to non-voting), accounting for 5.8314% of the total number of shares with valid voting rights for small and medium-sized shareholders attending this shareholders’ meeting.
- Considered and approved the "Proposal on Developing the Remuneration Management System for Directors and Senior Management Personnel"
Voting results: 74,173,782 shares were approved, accounting for 99.5002% of the total number of shares with valid voting rights present at this shareholders' meeting; 303,000 shares were opposed, accounting for 0.4065% of the total number of shares with valid voting rights present at this shareholders' meeting; 69,620 shares abstained (of which 8,820 shares abstained by default due to failure to vote) shares), accounting for 0.0934% of the total number of shares with valid voting rights present at this shareholders’ meeting.
Total voting results of small and medium shareholders:
622,000 shares were approved, accounting for 62.5364% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 303,000 shares were opposed, accounting for 30.4639% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting; 69,620 shares were abstained (of which 8,820 shares abstained by default due to failure to vote) shares), accounting for 6.9997% of the total number of shares with valid voting rights of small and medium-sized shareholders attending this shareholders' meeting.
3. Legal opinions issued by lawyers
Law firm name: Guoco Law Firm (Hangzhou)
Name of lawyer: Wang Shuaiqi, Zhang Rubing
Concluding comments:
The convening and convening procedures of this shareholders' meeting of Shandong Saito Biotechnology Co., Ltd., the qualifications of the attendees of this shareholders' meeting, the qualifications of the convener, the voting procedures and voting results of the meeting are all in compliance with the provisions of the "Company Law", "Shareholders' Meeting Rules", "Governance Code", "Listing Rules", "Online Voting Rules" and other laws, administrative regulations, normative documents and the "Company Articles" and "Shareholders' Meeting Rules of Procedure". The voting results passed by this shareholders' meeting are legal and valid.
4. Documents for reference
Resolution of the second extraordinary shareholders’ meeting of Shandong Saito Biotechnology Co., Ltd. in 2025;
Guoco Law Firm (Hangzhou) Legal Opinion on the Second Extraordinary Shareholders Meeting of Shandong Saito Biotechnology Co., Ltd. in 2025.
Announcement is hereby made.
Board of Directors of Shandong Saito Biotechnology Co., Ltd.
December 26, 2025